Cargando…
A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
BACKGROUND: Transarterial chemoembolization (TACE) is recommended for intermediate-stage HCC patients. Owing to substantial variation in its efficacy, indicators of patient responses to TACE need to be determined. METHODS: A Gene Expression Omnibus (GEO) dataset consisting of patients of different T...
Autores principales: | Tang, Yiyang, Wu, Yanqin, Xue, Miao, Zhu, Bowen, Fan, Wenzhe, Li, Jiaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803430/ https://www.ncbi.nlm.nih.gov/pubmed/35111225 http://dx.doi.org/10.1155/2022/3822773 |
Ejemplares similares
-
Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
por: Yao, Wang, et al.
Publicado: (2020) -
Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Zhang, Guixiong, et al.
Publicado: (2022) -
Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Wang, Hongyu, et al.
Publicado: (2020) -
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Fan, Wenzhe, et al.
Publicado: (2015) -
Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization
por: Fako, Valerie, et al.
Publicado: (2019)